Man

Eduardo René Parra Villegas

ACADÉMICO - ESCUELA DE MEDICINA

UNIVERSIDAD DE TARAPACA

Arica, Chile

Líneas de Investigación


Oncología Molecular, Inmunología Tumoral; Inmunología, Inmunoterapia; Terapia Génica, Vías de señalizaciones. Educación superior . Ciencias Empresariales

Educación

  •  MASTER OF SCIENCES, LUND UNIVERSITY. Suecia, 1993
  •  Post-Doctorado, Sidney Kimmel cancer Center. Estados Unidos, 2000
  •  MAGISTER EN GERENCIA PÚBLICA, UNIVERSIDAD ARTURO PRAT. Chile, 2018
  •  INGENIERO COMERCIAL, UNIVERSIDAD ARTURO PRAT. Chile, 2012
  •  BIOMEDICO, LUND UNIVERSITY. Suecia, 1992
  •  PROFESOR DE BIOLOGÍA Y CIENCIAS NATURALES, UNIVERSIDAD DE TARAPACÁ. Chile, 1984
  •  DOCTOR EN CIENCIAS MÉDICAS - INMUNOLOGÍA TUMORAL, UNIVERSIDAD DE LUND. Suecia, 1998

Experiencia Académica

  •   ACADÉMICO PROFESOR TITULAR 4 A Full Time

    UNIVERSIDAD DE TARAPACA

    CIENCIAS DE LA SALUD

    ARICA, Chile

    2016 - A la fecha

  •   DOCTORANDO Full Time

    UNIVERSIDAD DE LUND

    MEDICINA

    LUND, Suecia

    1993 - 1998

  •   ACADÉMICO Full Time

    UNIVERSIDAD DE CHILE

    MEDICINA

    SANTIAGO , Chile

    2002 - 2007

  •   ACADÉMICO PROFESOR TITULAR 4 A Full Time

    UNIVERSIDAD DE TARAPACÁ

    CIENCIAS

    ARICA, Chile

    2007 - 2016

Experiencia Profesional

  •   Académico

    Universidad de Tarapacá

    Chile

    2008 - A la fecha

  •   Académico

    Universidad de Chile

    Chile

    2001 - 2007

  •   Posdoctorado

    Sidney Kimmel Cancer Center

    Estados Unidos

    2000 - 2001

  •   Postdoctorado

    Baylor College of Medicine

    Estados Unidos

    1998 - 1999

  •   Doctorado/docencia

    Universidad de Lund

    Suecia

    1994 - 1998

  •   Master/docencia

    Universidad de Lund

    Suecia

    1992 - 1993

  •   Director del Laboratorio de Biomedicina Experimental

    Universidad de Tarapacá

    Chile

    2008 - 2015

  •   ACADÉMICO - ESCUELA DE MEDICINA

    UNIVERSIDAD DE TARAPACA

    Chile

    2016 - A la fecha


 

Article (21)

Decitabine Reactivate Secretoglobin (SCGB3A1) and SAP/JNK genes in Cisplatin Resistant PC-3 and LNCaP Prostate cell lines
Finding of exostoses in the external auditory channel of maritime workers in the port of Arica: Rescue of contemporary historical data
Determination of differences in dosimetry without and with intravenous contrast media for radiotherapy planning in the anatomical region of the head and neck
Differential effects of Platelet-derived growth factor on c-Jun-N-Terminal Kinase and AP-1/ NF-kB activities in human glioblastoma T98G cells.
Activation of Tax protein by c-Jun-N-terminal kinase is not dependent on the presence or absence of the early growth response-1 gene product
Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells
Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity
Antiproliferative and Uncoupling Effects of Delocalized, Lipophilic, Cationic Gallic Acid Derivatives on Cancer Cell Lines. Validation in Vivo in Singenic Mice
Association of increased levels of TGF-beta 1 and p14(ARF) in prostate carcinoma cell lines overexpressing Egr-1
An ortho-carbonyl substituted hydroquinone derivative is an anticancer agent that acts by inhibiting mitochondrial bioenergetics and by inducing G(2)/M-phase arrest in mammary adenocarcinoma TA3
Increased expression of p21(Waf1/Cip1) and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor
Relation of Breast Cancer and Malathion Aerial Spraying in Arica, Chile
Tumor cell death induced by the inhibition of mitochondrial electron transport: The effect of 3-hydroxybakuchiol
Development of a Panel of Genome-Wide Ancestry Informative Markers to Study Admixture Throughout the Americas
Inhibition of Egr-1 by siRNA in prostate carcinoma cell lines is associated with decreased expression of AP-1 and NF-kappa B
The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines
Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3
Indicators of identity and profile of the regional journalist in Chile Indicadores de identidad y perfil del periodista regional en Chile
Cell proliferation and tumor formation induced by eserine, an acetylcholinesterase inhibitor, in rat mammary gland
Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity
The MAP Kinases are Differently Utilized by CD28 and CD2 Adhesion Pathways in Superantigen-Activated Jurkat T cells

BookSection (4)

Response of glioma T98G cell line to wortmannin and platelet-derived Growth Factor
The Role of Tax Protein in the Regulation of IL-2 Production: Involvement of the c-Jun N Terminal Kinase
Leukemia T Cells as a Model to Study the Activity of the Phosphatase PP4 in the Regulation of T Cell Response.
The role of JNK, ERK and p38 mitogen activated protein kinases in the response of Jurkat T cells as a model for T cell activation

Review (1)

Plasticity of hippocampus following perinatal asphyxia: Effects on postnatal apoptosis and neurogenesis
26
Eduardo Parra

ACADÉMICO - ESCUELA DE MEDICINA

MEDICINA

UNIVERSIDAD DE TARAPACA

Arica, Chile

8
Jorge Ferreira

Director

Clinic and Molecular Farmacology

UNIVERSIDAD DE CHILE , FACULTAD DE MEDICINA, ICBM

Santiago, Chile

4
Juan Maya

Full Professor

Biomedical Sciences Institute

UNIVERSIDAD DE CHILE

Santiago, Chile

3
Leonardo Sáenz

Profesor Asociado

Ciencias Biológicas Animales

UNIVERSIDAD DE CHILE, FACULTAD DE CIENCIAS VETERINARIAS Y PECUARIAS

Santiago, Chile

3
José Jara

Assistant Professor

Research Institute of Dental Sciences

Universidad de Chile

Santiago, Chile

2
Ulrike Kemmerling

Full Professor

ICBM

Facultad de Medicina, Universidad de Chile

Santiago, Chile

2
Fabián Jaña

Profesor Asistente

Departamento de Ciencias de la Salud

Universidad de Aysén

Coyhaique, Chile

2
Gloria Calaf

Directora Laboratorio Biología del cáncer

Universidad de Tarapacá

Arica, Chile

2
Michel Lapier

Académico

Química y Farmacia

Universidad de Valparaíso

Valparaíso, Chile

1
Ramiro Araya

UNIVERSIDAD DE CHILE, FAC. CIENCIAS QUÍMICAS Y FARMACÉUTICAS, DPTO. QUÍMICA ORGÁNICA Y FISICOQUÍMICA

Santiago, Chile

1
elizabeth Parra

Profesora Asociado

Comunicación Social

Universidad de Concepcion

Concepción, Chile

1
Rodrigo Lopez

Profesor Asociado

Facultad de Ciencias Veterinarias

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

1
María Becker

Scientific Director, President

Research and Development

FUNDACIÓN CIENCIA Y TECNOLOGÍA PARA EL DESARROLLLO

Santiago, Chile

1
Julio Brito

DIRECTOR

INSTITUTO DE ESTUDIOS DE LA SALUD

UNIVERSIDAD ARTURO PRAT- INSTITUTO DE ESTUDIOS DE LA SALUD

IQUIQUE, Chile

1
Patricia Siques

Profesor titular

UNIVERSIDAD ARTURO PRAT, INSTITUTO DE ESTUDIOS DE LA SALUD

Iquique, Chile

1
Sergio Cárdenas

Coordinador de Investigación e investigador

Centro de Ingeniería y desarrollo sostenible

Universidad Central de Chile

Santiago, Chile

1
Mario Herrera-Marschitz

Profesor titular

Mol. & Clin. Pharmacology

UNIVERSIDAD DE CHILE, FACULTAD DE MEDICINA, PROGRAMA FARMACOLOGIA MOLECULAR & CLINICA, ICBM

Santiago, Chile

1
Bárbara Pesce

Profesora Asistente

ICBM

Universidad de Chile

Santiago, Chile